Summary: The fiscal year 2025 (FY25) Breast Cancer Research Program (BCRP) Clinical Research Extension Award aims to extend or expand the data collection, follow-up, and analysis of breast cancer...more
Summary: The Ovarian Cancer Investigator-Initiated Research Award (OCRP) Investigator-Initiated Research Award is intended to support high-impact research that addresses a critical need and has the...more
Summary: Supports research that expands or modifies current thinking about and/or approaches in ovarian cancer, exploring innovative concepts or theories in ovarian cancer that could ultimately lead...more
Summary: Supports promising research that has high potential to lead to or make breakthroughs in breast cancer. All applications must address at least one of the fiscal year 2025 (FY25) Breast Cancer...more
Summary: Supports promising research that has high potential to lead to or make breakthroughs in breast cancer. All applications must address at least one of the fiscal year 2025 (FY25) Breast Cancer...more
Summary: Supports individuals who are early in their careers with significant potential to effect meaningful change in breast cancer. As the intent of the fiscal year 2025 (FY25) Breast Cancer...more
Summary: The Ovarian Cancer Clinical Trial Academy (OCCTA) supports the next generation of Early-Career Investigators (ECIs) in clinical trial research to produce effective treatments and cures for...more
Summary: Supports non-incremental research designed to reduce risk of or prevent the development of Alzheimer’s disease and/or Alzheimer's disease related dementias (AD/ADRD). Allowable...more
Summary: The fiscal year 2025 (FY25) Amyotrophic Lateral Sclerosis Research Program (ALSRP) Therapeutic Development Award (TDA) supports research ranging from preclinical validation of therapeutic...more
John Converse Townsend, a Forbes contributor, shares what can the private sector do for a social enterprise. He encourages social enterprises to reach out to corporations for help to scale up their businesses.